Phase 3 Data Support a Novel Mechanism for Male Hair Loss: Spokane Dermatologist Dr. Wm. Philip Werschler on the Significance of the Clascoterone Results

SPOKANE, Wash., Aug. 11, 2026 (GLOBE NEWSWIRE) -- Recent Phase 3 results for clascoterone 5% topical solution, an investigational treatment for male androgenetic alopecia, are drawing attention across dermatology because they point toward a...